11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.

Islam R, Briscoe C, Bower J, Cape S, Arnold M, Hayes R, Warren M, Karnik S, Stouffer B, Xiao YQ, van der Strate B, Sikkema D, Fang X, Tudoroniu A, Tayyem R, Brant A, Spriggs F, Barry C, Khan M, Keyhani A, Zimmer J, Caturla MC, Couerbe P, Khadang A, Bourdage J, Datin J, Zemo J, Hughes N, Fatmi S, Sheldon C, Fountain S, Satterwhite C, Colletti K, Vija J, Yu M, Stamatopoulos J, Lin J, Wilfahrt J, Dinan A, Ohorodnik S, Hulse J, Patel V, Garofolo W, Savoie N, Brown M, Papac D, Buonarati M, Hristopoulos G, Beaver C, Boudreau N, Williard C, Liu Y, Ray G, Warrino D, Xu A, Green R, Hayward-Sewell J, Marcelletti J, Sanchez C, Kennedy M, Charles JS, Bouhajib M, Nehls C, Tabler E, Tu J, Joyce P, Iordachescu A, DuBey I, Lindsay J, Yamashita J, Wells E

Open source

DOI
10.4155/bio-2018-0014
Published
2018 Apr 1
Container
Bioanalysis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4155/bio-2018-0014,
  title = {11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.},
  author = {Islam R and Briscoe C and Bower J and Cape S and Arnold M and Hayes R and Warren M and Karnik S and Stouffer B and Xiao YQ and van der Strate B and Sikkema D and Fang X and Tudoroniu A and Tayyem R and Brant A and Spriggs F and Barry C and Khan M and Keyhani A and Zimmer J and Caturla MC and Couerbe P and Khadang A and Bourdage J and Datin J and Zemo J and Hughes N and Fatmi S and Sheldon C and Fountain S and Satterwhite C and Colletti K and Vija J and Yu M and Stamatopoulos J and Lin J and Wilfahrt J and Dinan A and Ohorodnik S and Hulse J and Patel V and Garofolo W and Savoie N and Brown M and Papac D and Buonarati M and Hristopoulos G and Beaver C and Boudreau N and Williard C and Liu Y and Ray G and Warrino D and Xu A and Green R and Hayward-Sewell J and Marcelletti J and Sanchez C and Kennedy M and Charles JS and Bouhajib M and Nehls C and Tabler E and Tu J and Joyce P and Iordachescu A and DuBey I and Lindsay J and Yamashita J and Wells E},
  year = {2018},
  journal = {Bioanalysis},
  doi = {10.4155/bio-2018-0014},
  url = {https://doi.org/10.4155/bio-2018-0014}
}

RIS

TY  - JOUR
TI  - 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.
AU  - Islam R
AU  - Briscoe C
AU  - Bower J
AU  - Cape S
AU  - Arnold M
AU  - Hayes R
AU  - Warren M
AU  - Karnik S
AU  - Stouffer B
AU  - Xiao YQ
AU  - van der Strate B
AU  - Sikkema D
AU  - Fang X
AU  - Tudoroniu A
AU  - Tayyem R
AU  - Brant A
AU  - Spriggs F
AU  - Barry C
AU  - Khan M
AU  - Keyhani A
AU  - Zimmer J
AU  - Caturla MC
AU  - Couerbe P
AU  - Khadang A
AU  - Bourdage J
AU  - Datin J
AU  - Zemo J
AU  - Hughes N
AU  - Fatmi S
AU  - Sheldon C
AU  - Fountain S
AU  - Satterwhite C
AU  - Colletti K
AU  - Vija J
AU  - Yu M
AU  - Stamatopoulos J
AU  - Lin J
AU  - Wilfahrt J
AU  - Dinan A
AU  - Ohorodnik S
AU  - Hulse J
AU  - Patel V
AU  - Garofolo W
AU  - Savoie N
AU  - Brown M
AU  - Papac D
AU  - Buonarati M
AU  - Hristopoulos G
AU  - Beaver C
AU  - Boudreau N
AU  - Williard C
AU  - Liu Y
AU  - Ray G
AU  - Warrino D
AU  - Xu A
AU  - Green R
AU  - Hayward-Sewell J
AU  - Marcelletti J
AU  - Sanchez C
AU  - Kennedy M
AU  - Charles JS
AU  - Bouhajib M
AU  - Nehls C
AU  - Tabler E
AU  - Tu J
AU  - Joyce P
AU  - Iordachescu A
AU  - DuBey I
AU  - Lindsay J
AU  - Yamashita J
AU  - Wells E
PY  - 2018
JO  - Bioanalysis
DO  - 10.4155/bio-2018-0014
UR  - https://doi.org/10.4155/bio-2018-0014
ER  - 

APA

R, I., C, B., J, B., S, C., M, A., R, H., M, W., S, K., B, S., YQ, X., B, V. D. S., D, S., X, F., A, T., R, T., A, B., F, S., C, B., M, K., A, K., J, Z., MC, C., P, C., A, K., J, B., J, D., J, Z., N, H., S, F., C, S., S, F., C, S., K, C., J, V., M, Y., J, S., J, L., J, W., A, D., S, O., J, H., V, P., W, G., N, S., M, B., D, P., M, B., G, H., C, B., N, B., C, W., Y, L., G, R., D, W., A, X., R, G., J, H., J, M., C, S., M, K., JS, C., M, B., C, N., E, T., J, T., P, J., A, I., I, D., J, L., J, Y., & E, W. (2018). 11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.. Bioanalysis. https://doi.org/10.4155/bio-2018-0014

Source records